News

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.
A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity.
Alembic Pharmaceuticals shares surged over 12 per cent after receiving USFDA approval for its generic Doxorubicin ...
The generic drug contains cefovecin sodium, the same active ingredient in Convenia (Zoetis Inc), which was approved by the ...
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
Shares of Alembic Pharmaceuticals climbed over 12% after the company secured USFDA approval for its generic Doxorubicin ...
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
But there is a new, first-of-its-kind drug to prevent these attacks: The U.S. Food and Drug Administration (FDA) has approved Andembry (garadacimab), a once-monthly medicine injected under the ...
It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.
A UroGen Pharma Ltd. investor has dropped his suit against the drug developer after the FDA approved the company’s new ...